Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Walter Morton who wrote (2472)	9/9/1999 6:51:00 PM
From: Walter Morton	Read Replies (1) of 2742

CIST claims to have patents on PAI-2 and considers Biotech Australia a business partner. Yet Biotech Australia claims to have patents on PAI-2 also. I'm going to do a little more research on this to see where CIST's patents stop and Biotech Australia's patents begins. In other words, will CIST make any money on this new ulcer medication? The email address at Genome securities does not work and Cistron will not respond to my emails. So, this may take some time to figure out.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next